NEWARK BETH ISRAEL MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4M
- Transactions
- 821
- Companies
- 40
- Average per transaction
- $4,835
Who reported the payments
| Gilead | $1,360,435 |
| Edwards Lifesciences | $662,834 |
| Abbott | $405,611 |
| Jazz Pharmaceuticals Inc. | $364,938 |
| Boston Scientific | $152,668 |
| Linde Gas & Equipment Inc. | $139,260 |
| Amgen | $117,823 |
| Pfizer | $97,742 |
| Astellas Pharma Global Development | $58,000 |
| Janssen Research & Development, LLC | $51,353 |
| Regeneron | $48,179 |
| Eli Lilly | $47,798 |
| Novartis | $45,344 |
| Bolton Medical Inc | $38,509 |
| United Therapeutics Corporation | $32,297 |
| ZOLL Circulation Inc | $29,450 |
| Actelion Pharmaceuticals, Ltd | $26,625 |
| Array Biopharma Inc | $23,145 |
| Cardiovascular Systems Inc. | $21,625 |
| Daiichi Sankyo Inc. | $20,223 |
| Medtronic | $20,044 |
| Gyrus ACMI, Inc. | $19,560 |
| Johnson & Johnson | $19,344 |
| Roche Products Limited | $16,625 |
| Genentech, Inc. | $16,133 |
| Olympus America Inc. | $14,828 |
| Merck | $13,672 |
| Stryker | $13,156 |
| Neoss, Inc. | $10,802 |
| Cleerly, Inc. | $9,440 |
| Global Blood Therapeutics, Inc. | $8,847 |
| Bayer | $8,254 |
| Actelion Pharmaceuticals US, Inc. | $6,541 |
| Mallinckrodt Hospital Products Inc. | $6,000 |
| Cook Research Incorporated | $5,720 |
| Incyte Corporation | $5,108 |
| Shockwave Medical, Inc | $5,001 |
| W. L. Gore & Associates, Inc. | $4,952 |
| Fisher & Paykel Healthcare Inc | $3,936 |
| Bristol Myers Squibb | $3,000 |